Free public records show Helmholtz Zentrum München in 1 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by Helmholtz Zentrum München or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
Source: Wikidata, Company record Q878592. Retrieved 13 Nov 2026.
3 active studies led by Helmholtz Zentrum München, of 3 in all
Source: ClinicalTrials.gov, Studies with Helmholtz Zentrum München (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Studies Helmholtz Zentrum München leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with Helmholtz Zentrum München or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets we cover where free public records show Helmholtz Zentrum München: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Helmholtz Zentrum München is in.
Stories on the topics Helmholtz Zentrum München works in.
Nearly 15% of US Medicare beneficiaries, 8.2 million people, had a wound or wound infection in one year…
Read
Atrial fibrillation raises stroke risk about five-fold. Holter monitors, patches, implants and smartwatches…
Read
Over 9.5 million people live with type 1 diabetes and need insulin every day. How delivery devices are…
ReadSearch all reports for Helmholtz Zentrum München All companies